Personalized cancer attack: new trial matches drugs to tumor genes
NCT ID NCT04589845
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This phase II trial tests whether giving cancer drugs based on a tumor's genetic makeup can help people with advanced solid tumors that cannot be removed by surgery or have spread. About 920 participants will receive a drug or drug combination tailored to their tumor's specific gene changes. The main goal is to see how many participants have their tumors shrink or disappear.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Entrectinib (Rozlytrek) and other targeted therapies or immunotherapies
- What this could lead to
- If successful, this trial could show that matching cancer treatment to a tumor's genetic profile helps shrink or control advanced solid tumors that have not responded to standard therapy.
- What could go wrong
- This is an early-phase (phase II) trial with no control group, so results may not prove effectiveness. The drugs may cause side effects or stop working over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alliance Cancer Specialists
Horsham, Pennsylvania, 19044, United States
-
Asan Medical Center
Seoul, 05505, South Korea
-
Asst Degli Spedali Civili Di Brescia
Brescia, Lombardy, 25100, Italy
-
Auckland City Hospital, Cancer and Blood Research
Auckland, 1023, New Zealand
-
Azienda Ospedaliera Universitaria Senese, U.O.C. Immunoterapia Oncologica
Siena, Tuscany, 53100, Italy
-
BC Cancer ? Vancouver
Vancouver, British Columbia, V5Z 1J3, Canada
-
Barrett Cancer Center
Cincinnati, Ohio, 45219, United States
-
Beatson West of Scotland Cancer Centre
Glasgow, G12 0YN, United Kingdom
-
Beijing Cancer Hospital
Beijing, 100142, China
-
Beijing Children's Hospital, Capital Medical University
Beijing, China
-
Cancer Treatment Centers of America
Philadelphia, Pennsylvania, 19124, United States
-
Centre Leon Berard
Lyon, 69373, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Chang Gung Memorial Hospital-Linkou
Taoyuan County, 333, Taiwan
-
Clinica Universidad de Navarra Madrid
Madrid, 28027, Spain
-
Cliniques Universitaires St-Luc
Brussels, 1200, Belgium
-
Clínica Onco Star - Rede D'Or
São Paulo, São Paulo, 04543-000, Brazil
-
Consultants in Medical Oncology and Hematology
Broomall, Pennsylvania, 19008, United States
-
Dipartimento di Scienze Pediatriche Adolescenza
Turin, Piedmont, 10126, Italy
-
First Affiliated Hospital of Medical College of Xi'an Jiaotong University
Xi'an, 710061, China
-
Froedtert and The Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
GHdC Site Les Viviers
Charleroi, 6060, Belgium
-
Georg-August-Uniklinik
Göttingen, 37075, Germany
-
Hadassah University Hospital - Ein Kerem
Jerusalem, 9112001, Israel
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Hoag Memorial Hospital
Newport Beach, California, 92658, United States
-
Hong Kong Children's Hospital
Hong Kong, Hong Kong
-
Hopital de la Timone
Marseille, 13005, France
-
Horizon Oncology Research, Inc.
Lafayette, Indiana, 47905, United States
-
Hospital A. C. Camargo
São Paulo, São Paulo, 01509-010, Brazil
-
Hospital Infantil Universitario Nino Jesus
Madrid, 28009, Spain
-
Hospital Sant Joan De Deu
Esplugues de Llobregas, Barcelona, 08950, Spain
-
Hospital Sírio-Libanês
São Paulo, São Paulo, 01308-050, Brazil
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario la Fe
Valencia, 46026, Spain
-
IPO do Porto
Porto, 4200-072, Portugal
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Inselspital, Klinik und Poliklinik für Medizinische Onkologie
Bern, 3010, Switzerland
-
Institut Bergonie
Bordeaux, 33076, France
-
Institut Universitaire du Cancer de Toulouse-Oncopole
Toulouse, 31059, France
-
Institut de Cancerologie Gustave-Roussy (IGR)
Villejuif, 94805, France
-
Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana
Billings, Montana, 59102, United States
-
Irccs Istituto Nazionale Dei Tumori (Int)
Milan, Lombardy, 20133, Italy
-
Istituto Nazionale Tumori di Milano
Milan, Lombardy, 20133, Italy
-
Kaiser Permanente Los Angeles
Los Angeles, California, 90027, United States
-
Kindai University Hospital
Osaka, 589-8511, Japan
-
Kinghorn Cancer Centre
Darlinghurst, New South Wales, 2010, Australia
-
Mary Crowley Medical Research Center
Dallas, Texas, 75230, United States
-
Maryland Hematology & Oncology. P.A.
Silver Spring, Maryland, 20904, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 11101, United States
-
Metro-Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, 55416, United States
-
Midwestern Regional Med Center
Zion, Illinois, 60099, United States
-
Montefiore Einstein Center for Cancer Care
The Bronx, New York, 10461, United States
-
Narod.Inst.Onkol. im. M.Sklodowskiej - Curie-Panst.Inst.Bad
Warsaw, 02-781, Poland
-
National Cancer Center Hospital
Tokyo, 104-0045, Japan
-
National Cancer Centre
Singapore, 168583, Singapore
-
National Cheng Kung University Hospital
Tainan, 00704, Taiwan
-
National Taiwan University Hospital
Zhongzheng Dist., 10048, Taiwan
-
National University Hospital
Singapore, 119228, Singapore
-
Northwest Medical Specialties, PLLC
Tacoma, Washington, 98405, United States
-
Oncology Hematology Care Inc
Cincinnati, Ohio, 45242, United States
-
Ospedale Pediatrico Bambino Gesù - IRCCS
Rome, Lazio, 00165, Italy
-
PanOncology Trials
San Juan, 00935, Puerto Rico
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Policlinico Universitario Agostino Gemelli IRCCS
Rome, Lazio, 00168, Italy
-
Praxis für Hämatologie, Onkologie und Palliativmedizin
Mönchengladbach, 41066, Germany
-
Prince of Wales Hospital
Shatin, Hong Kong
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Rabin MC
Petah Tikva, 4941492, Israel
-
Rigshospitalet
København Ø, 2100, Denmark
-
Royal Children's Hospital
Parkville, Victoria, 3052, Australia
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08901, United States
-
SLK-Kliniken Heilbronn GmbH;Klinik für Innere Medizin III
Heilbronn, 74078, Germany
-
START Madrid-FJD, Hospital Fundacion Jimenez Diaz
Madrid, 28040, Spain
-
START Madrid. Centro Integral Oncologico Clara Campal
Madrid, 28050, Spain
-
Samsung Medical Center- Adult Site
Seoul, 06351, South Korea
-
Samsung Medical Center- Pediatric Site
Seoul, 06351, South Korea
-
Seoul National University Bundang Hospital
Gyeonggi-do, 13620, South Korea
-
Seoul National University Hospital- Adult Site
Seoul, 03080, South Korea
-
Seoul National University Hospital- Pediatric Site
Seoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, 03722, South Korea
-
Sheba Medical Center
Ramat Gan, 5262100, Israel
-
Sourasky / Ichilov Hospital
Tel Aviv, 6423906, Israel
-
St. Alphonsus
Boise, Idaho, 83706, United States
-
St. Jude Children'S Research Hospital
Memphis, Tennessee, 38105, United States
-
Taipei Veterans General Hospital
Taipei, 112201, Taiwan
-
Texas Oncology - Baylor Charles A. Sammons Cancer Center
Dallas, Texas, 75246, United States
-
Texas Oncology - Central South
Austin, Texas, 78731, United States
-
Texas Oncology- Northeast Texas
Tyler, Texas, 75702, United States
-
The Christie NHS Foundation Trust
Manchester, M20 4BX, United Kingdom
-
The Hospital for Sick Children
Toronto, Ontario, M5G 1H3, Canada
-
The Ottawa Hospital - General Campus
Ottawa, Ontario, K1H 8L6, Canada
-
The West Clinic
Germantown, Tennessee, 38138, United States
-
Tianjin Cancer Hospital
Tianjin, 300060, China
-
UC Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
-
USC Norris Cancer Center
Los Angeles, California, 90033, United States
-
UZ Antwerpen
Edegem, 2650, Belgium
-
UZ Gent
Ghent, 9000, Belgium
-
UZ Leuven Gasthuisberg
Leuven, 3000, Belgium
-
Uniklinik Essen
Essen, 45122, Germany
-
University Cancer & Blood Center, LLC
Athens, Georgia, 30607, United States
-
University College London Hospital
London, NW1 - 2PG, United Kingdom
-
University of New Mexico
Albuquerque, New Mexico, 87131, United States
-
Uniwersyteckie Centrum Kliniczne, Klinika Onkologii i Radioterapii
Gda?sk, 80-214, Poland
-
Vall d'Hebron Institute of Oncology (VHIO), Barcelona
Barcelona, 08035, Spain
-
Vall d?Hebron Institute of Oncology (VHIO), Barcelona
Barcelona, 08035, Spain
-
Virginia Cancer Specialists - Leesburg
Leesburg, Pennsylvania, 20176, United States
-
West China Hospital - Sichuan University
Chengdu, 610047, China
-
Western Regional Medical Center at Cancer Treatment Centers of America
Goodyear, Arizona, 85338, United States
-
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, 200092, China
-
Zhongshan Hospital Fudan Unvierstiy
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can your own immune cells beat advanced cancer?
- Can a Dual-Pronged antibody outsmart advanced solid tumors?
- Can a new infusion drug shrink Hard-to-Treat tumors?
- Tumor DNA mapping may unlock personalized cancer therapies
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a protein calm the immune System's overreaction to cancer treatment?